Filing Details
- Accession Number:
- 0001179110-17-011721
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2017-08-22 12:58:22
- Reporting Period:
- 2017-08-21
- Accepted Time:
- 2017-08-22 11:58:22
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 896264 | Usana Health Sciences Inc | USNA | Medicinal Chemicals & Botanical Products (2833) | 870500306 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1441438 | James Bramble | 3838 West Parkway Blvd. Salt Lake City UT 84120 | Chief Legal Officer And Sec | No | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2017-08-21 | 18,298 | $28.81 | 20,374 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2017-08-21 | 18,298 | $57.01 | 2,076 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | M | Direct | |
| No | 4 | S | Direct |
Reported Derivative Transactions
| Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
|---|---|---|---|---|---|---|---|
| Common Stock | Stock Settled Stock Appreciation Rights | Disposition | 2017-08-21 | 37,000 | $0.00 | 37,000 | $28.81 |
| Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
|---|---|---|---|---|---|---|
| 0 | 2016-08-15 | 2018-03-15 | No | 4 | M | Direct |
Footnotes
- The shares acquired resulted from the reporting person's settlement of the stock-setteld stock appreciation rights disclosed in Table-II
- Weighted average price $57.0147. Price range in multiple transactions was $57.00 to $57.30 inclusively.
Billionaire Hedge Funds
